ID   SUGPH_MYCTU             Reviewed;         203 AA.
AC   Q6MWZ7; I6YFI9;
DT   07-SEP-2016, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   07-APR-2021, entry version 116.
DE   RecName: Full=Acid phosphatase {ECO:0000303|PubMed:16672613};
DE            EC=3.1.3.2 {ECO:0000269|PubMed:16672613};
DE   AltName: Full=Broad-specificity phosphatase {ECO:0000303|PubMed:16672613};
DE   AltName: Full=Fructose-1,6-bisphosphatase {ECO:0000303|PubMed:26258286};
DE            Short=FBPase {ECO:0000303|PubMed:26258286};
DE            EC=3.1.3.11 {ECO:0000269|PubMed:26258286};
GN   Name=gpm2 {ECO:0000303|PubMed:26258286, ECO:0000312|EMBL:CCP46030.1};
GN   OrderedLocusNames=Rv3214 {ECO:0000312|EMBL:CCP46030.1},
GN   LH57_17570 {ECO:0000312|EMBL:AIR16007.1};
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 27294 / TMC 102 / H37Rv;
RA   Hazbon M.H., Riojas M.A., Damon A.M., Alalade R.O., Cantwell B.J.,
RA   Monaco A., King S., Sohrabi A.;
RT   "Phylogenetic analysis of Mycobacterial species using whole genome
RT   sequences.";
RL   Submitted (SEP-2014) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION AS A FBPASE, CATALYTIC
RP   ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY REGULATION, DISRUPTION
RP   PHENOTYPE, AND PATHWAY.
RC   STRAIN=H37Rv;
RX   PubMed=26258286; DOI=10.1038/ncomms8912;
RA   Ganapathy U., Marrero J., Calhoun S., Eoh H., de Carvalho L.P., Rhee K.,
RA   Ehrt S.;
RT   "Two enzymes with redundant fructose bisphosphatase activity sustain
RT   gluconeogenesis and virulence in Mycobacterium tuberculosis.";
RL   Nat. Commun. 6:7912-7912(2015).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS), FUNCTION AS A BROAD-SPECTRUM
RP   PHOSPHATASE, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE
RP   SPECIFICITY, AND SUBUNIT.
RC   STRAIN=H37Rv;
RX   PubMed=16672613; DOI=10.1128/jb.188.10.3589-3599.2006;
RA   Watkins H.A., Baker E.N.;
RT   "Structural and functional analysis of Rv3214 from Mycobacterium
RT   tuberculosis, a protein with conflicting functional annotations, leads to
RT   its characterization as a phosphatase.";
RL   J. Bacteriol. 188:3589-3599(2006).
CC   -!- FUNCTION: Phosphatase with a broad specificity. Can dephosphorylate a
CC       variety of substrates including phosphorylated sugars like fructose-6-
CC       phosphate (F6P) (PubMed:16672613). Is able to function in vivo as a
CC       fructose-1,6-bisphosphatase (FBPase) and to maintain gluconeogenesis
CC       when the classical FBPase GlpX is absent (PubMed:26258286). Shows
CC       negligible phosphoglycerate mutase activity (PubMed:16672613). Has no
CC       phosphatase activity against 3-phosphoglycerate, 2,3-
CC       bisphosphoglycerate, or hydrophobic substrates such as alpha-napthyl
CC       phosphate (PubMed:16672613). {ECO:0000269|PubMed:16672613,
CC       ECO:0000269|PubMed:26258286}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a phosphate monoester + H2O = an alcohol + phosphate;
CC         Xref=Rhea:RHEA:15017, ChEBI:CHEBI:15377, ChEBI:CHEBI:30879,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:67140; EC=3.1.3.2;
CC         Evidence={ECO:0000269|PubMed:16672613};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=beta-D-fructose 1,6-bisphosphate + H2O = beta-D-fructose 6-
CC         phosphate + phosphate; Xref=Rhea:RHEA:11064, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:32966, ChEBI:CHEBI:43474, ChEBI:CHEBI:57634; EC=3.1.3.11;
CC         Evidence={ECO:0000269|PubMed:26258286};
CC   -!- ACTIVITY REGULATION: In contrast to classical FBPases, is resistant to
CC       inhibition by lithium. {ECO:0000269|PubMed:26258286}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.04 mM for p-nitrophenyl phosphate (at pH 5.5 and 37 degrees
CC         Celsius) {ECO:0000269|PubMed:16672613};
CC         KM=101.1 uM for 3-phosphoglycerate {ECO:0000269|PubMed:16672613};
CC         Note=kcat is 0.00071 sec(-1) for phosphoglycerate mutase activity
CC         (PubMed:16672613). The enzyme's FBPase activity does not follow
CC         Michaelis-Menten kinetics but follows allosteric sigmoidal kinetics
CC         that show lower affinity for FBP compared with GlpX, but the enzyme's
CC         higher turnover number makes it a robust FBPase at high FBP
CC         concentrations (PubMed:26258286). {ECO:0000269|PubMed:16672613,
CC         ECO:0000269|PubMed:26258286};
CC       pH dependence:
CC         Optimum pH is 5.4 for phosphatase activity using pNPP as the
CC         substrate. {ECO:0000269|PubMed:16672613};
CC   -!- PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.
CC       {ECO:0000305|PubMed:26258286}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16672613}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking both glpX and gpm2 grow as well as
CC       wild-type on glucose, but are unable to grow on any of the
CC       gluconeogenic carbon sources tested (glycerol, acetate and butyrate);
CC       the growth defect on gluconeogenic carbon sources is fully complemented
CC       by restoring expression of either GlpX or Gpm2. This double mutant
CC       lacks detectable FBPase activity and accumulates FBP. It is also
CC       severely attenuated in a mouse model of infection, as it fails to
CC       replicate in mouse lungs during the first 10 days of infection and
CC       begins to die thereafter. {ECO:0000269|PubMed:26258286}.
CC   -!- MISCELLANEOUS: Gluconeogenesis is critical to M.tuberculosis ability to
CC       establish infection and is necessary for its survival in the host.
CC       {ECO:0000269|PubMed:26258286}.
CC   -!- SIMILARITY: Belongs to the phosphoglycerate mutase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP009480; AIR16007.1; -; Genomic_DNA.
DR   EMBL; AL123456; CCP46030.1; -; Genomic_DNA.
DR   RefSeq; WP_003416878.1; NZ_NVQJ01000003.1.
DR   RefSeq; YP_177944.1; NC_000962.3.
DR   PDB; 2A6P; X-ray; 2.20 A; A/B=1-203.
DR   PDBsum; 2A6P; -.
DR   SMR; Q6MWZ7; -.
DR   STRING; 83332.Rv3214; -.
DR   PaxDb; Q6MWZ7; -.
DR   GeneID; 45427207; -.
DR   GeneID; 888830; -.
DR   KEGG; mtu:Rv3214; -.
DR   PATRIC; fig|83332.111.peg.3589; -.
DR   TubercuList; Rv3214; -.
DR   eggNOG; COG0406; Bacteria.
DR   HOGENOM; CLU_033323_13_1_11; -.
DR   InParanoid; Q6MWZ7; -.
DR   OMA; GWLIWRD; -.
DR   PhylomeDB; Q6MWZ7; -.
DR   UniPathway; UPA00138; -.
DR   EvolutionaryTrace; Q6MWZ7; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0003993; F:acid phosphatase activity; IDA:MTBBASE.
DR   GO; GO:0042132; F:fructose 1,6-bisphosphate 1-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:MTBBASE.
DR   GO; GO:0006094; P:gluconeogenesis; IEA:UniProtKB-UniPathway.
DR   CDD; cd07067; HP_PGM_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR013078; His_Pase_superF_clade-1.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   Pfam; PF00300; His_Phos_1; 1.
DR   SMART; SM00855; PGAM; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Carbohydrate metabolism; Gluconeogenesis; Hydrolase;
KW   Reference proteome.
FT   CHAIN           1..203
FT                   /note="Acid phosphatase"
FT                   /id="PRO_0000437244"
FT   ACT_SITE        13
FT                   /note="Tele-phosphohistidine intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:P36136,
FT                   ECO:0000305|PubMed:16672613"
FT   ACT_SITE        85
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P36136"
FT   SITE            147
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P36136"
SQ   SEQUENCE   203 AA;  21949 MW;  25293CE08DD88D55 CRC64;
     MGVRNHRLLL LRHGETAWST LGRHTGGTEV ELTDTGRTQA ELAGQLLGEL ELDDPIVICS
     PRRRTLDTAK LAGLTVNEVT GLLAEWDYGS YEGLTTPQIR ESEPDWLVWT HGCPAGESVA
     QVNDRADSAV ALALEHMSSR DVLFVSHGHF SRAVITRWVQ LPLAEGSRFA MPTASIGICG
     FEHGVRQLAV LGLTGHPQPI AAG
//
